Search Results - "Halpenny, D.F."

Investigation of patterns of nodal metastases in BRAF mutant lung cancer by McEvoy, S.H., MB BCh BAO, Halpenny, D.F., MB BCh BAO, Viteri-Jusué, A., MD, Hayes, S.A., MD, Plodkowski, A.J., MD, Riely, G.J., MD, Ginsberg, M.S., MD

“…Highlights • Axillary lymph nodes are a rare site of nodal metastases in lung cancer patients. • BRAF mutated NSCLC patients have a higher incidence of…”
Get full text

Re: Spindle cell sarcoma of the profundua femoris vein, mimicking deep venous thrombosis by Halpenny, D.F, Buckley, O, Torreggiani, W.C

Get full text

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers by Sabari, J.K., Leonardi, G.C., Shu, C.A., Umeton, R., Montecalvo, J., Ni, A., Chen, R., Dienstag, J., Mrad, C., Bergagnini, I., Lai, W.V., Offin, M., Arbour, K.C., Plodkowski, A.J., Halpenny, D.F., Paik, P.K., Li, B.T., Riely, G.J., Kris, M.G., Rudin, C.M., Sholl, L.M., Nishino, M., Hellmann, M.D., Rekhtman, N., Awad, M.M., Drilon, A.

“…MET exon 14 alterations are actionable oncogenic drivers. Durable responses to MET inhibitors are observed in patients with advanced MET exon 14-altered lung…”
Get full text

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer by Hastings, K., Yu, H.A., Wei, W., Sanchez-Vega, F., DeVeaux, M., Choi, J., Rizvi, H., Lisberg, A., Truini, A., Lydon, C.A., Liu, Z., Henick, B.S., Wurtz, A., Cai, G., Plodkowski, A.J., Long, N.M., Halpenny, D.F., Killam, J., Oliva, I., Schultz, N., Riely, G.J., Arcila, M.E., Ladanyi, M., Zelterman, D., Herbst, R.S., Goldberg, S.B., Awad, M.M., Garon, E.B., Gettinger, S., Hellmann, M.D., Politi, K.

“…Although EGFR mutant tumors exhibit low response rates to immune checkpoint blockade overall, some EGFR mutant tumors do respond to these therapies; however,…”
Get full text

Imaging following thermal ablation of early lung cancers: expected post-treatment findings and tumour recurrence by Das, J.P., Barry, C., Schöder, H., Camacho, J.C., Ginsberg, M.S., Halpenny, D.F.

“…Thermal ablation is a minimally invasive technique that is growing in acceptance and popularity in the management of early lung cancers. Although curative…”
Get full text

LKB1 loss is a novel genomic predictor of de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma by Skoulidis, F., Hellman, M.D., Awad, M., Gainor, J.F., Rizvi, H., Carter, B., Denning, W.L., Villalobos, P., Parra, E.R., Elamin, Y.Y., Zhang, J., Leonardi, G.C., Halpenny, D.F., Papadimitrakopoulou, V., Wistuba, I.I., Wolchok, J.D., Shaw, A.T., Jänne, P.A., Rudin, C.M., Heymach, J.V.

Get full text

Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer by Goncalves, M.D., Taylor, S., Halpenny, D.F., Schwitzer, E., Gandelman, S., Jackson, J., Lukose, A., Plodkowski, A.J., Tan, K.S., Dunphy, M., Jones, L.W., Downey, R.J.

“…To assess whether changes in body composition could be assessed serially using conventional thoracic computed tomography (CT) and positron-emission tomography…”
Get full text